FMC Investment

The firm sources through the industrial and financial networks of its parent, FMC Group, and through partnerships with overseas infrastructure collaborators. Its website emphasizes long-term trust with investors and partners as the foundation for portfolio construction, though named sourcing channels remain unpublished.

FMC Investment operates as both. The firm is described as the core VC and asset-management entity within FMC Group, conducting venture investing across stages while simultaneously managing assets. This dual structure allows it to deploy capital directly into startups and offer asset-management services, though the client base is not disclosed.

The firm covers early stage, seed, startup, and expansion or late-stage rounds, according to its strategic materials. This range suggests a flexible mandate that can support company formation, growth equity, and pre-IPO positioning.

Named investment leads or key executives are not publicly identified on the firm's website or in available primary sources. The site references 'partners and investment professionals' but does not list individuals, making it difficult to confirm who holds decision-making authority.

No explicit exclusion list is published. The firm's communicated focus is biotech, medical healthcare, and ICT, with additional mentions of fintech and renewable energy. Sectors outside these areas receive no public emphasis, which may indicate a de facto avoidance but is not stated as policy.